SAVE THE DATE - Multiple Sclerosis Symposium June 4th -5th, 2015

MS 2Symposium Flyer 2015

UAB launches study of cannabidiol oil for severe seizures

The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.  

   epilepsy2The University of Alabama at Birmingham has launched two studies of cannabidiol oil, or CBD oil, as a treatment for severe, intractable seizures. The two studies, an adult study at UAB and a pediatric study at Children’s of Alabama, were authorized by the Alabama Legislature in 2014 by legislation known as Carly’s Law.

The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.

“We are extremely pleased to launch these exciting studies,” said David Standaert, M.D., Ph.D., chair of the Department of Neurology. “What we learn from these investigations could have a profound impact on the lives of many adults and children with uncontrolled seizures. We are honored to have been entrusted with this effort by the Alabama Legislature, and we look forward to getting the studies underway.”

UAB will enroll 100 subjects in the two studies, 50 adult patients and 50 pediatric patients. Potential study subjects must apply to the UAB Cannabidiol Program for inclusion in the studies. Each application, which must include a referral from a patient’s primary treating neurologist, will be reviewed by a panel of UAB neurologists. Patients must meet necessary qualifications in order to be enrolled. Applications will be reviewed in the order in which they are received. Information on how to apply for enrollment can be found on the UAB Cannabidiol website at www.uab.edu/cbd.

Information on how to apply for enrollment can be found on the UAB Cannabidiol website at www.uab.edu/cbd.

Initial appointments will be scheduled as patients are enrolled. All patients in the studies will receive CBD oil.

UAB has contracted with a vendor to supply the oil, which is available only in very limited quantities nationwide. The vendor, who is providing the oil at no charge, has capped the amount of oil available for use in the UAB studies at enough to treat 100 patients, which would make the UAB studies among the largest in the nation. If more than 100 patients qualify for inclusion in the studies, UAB will investigate the possibility of expanding the studies.

By: Bob Shepard



Anthony P. Nicholas, MD, PhD Recipient of 2015 President's Award for Excellence in Teaching

nicholas  The Department of Neurology is proud to announce Anthony P. Nicholas, M.D., Ph.D., is the 2015 recipient of the President’s Award for Excellence in Teaching in the UAB School of Medicine. This award recognizes full-time, regular faculty members of UAB who have demonstrated exceptional accomplishments in teaching. Dr. Nicholas has an impressive track record of teaching awards. Previously, he has received a total of 18 Argus Awards in six different categories, including four times as best small group instructor, best overall lecturer of the MS2 class, and best individual lecturer in neuroscience; twice in correlative pathology and neuropathology; and finally, once in pharmacology. He has given over 700 formal lectures and presentations on over 40 different topics at UAB and averages over 50 hours of formal lectures per year for a total of 1,073 hours since starting as faculty at UAB in 1996.

This is an extraordinary level of commitment to our teaching mission, and we are very pleased that the University has chosen to honor Dr. Nicholas with such a high honor this year.
   

UAB symposium to examine brain-machine interface

National and local experts in biomedical engineering, neuroscience and rehabilitation will gather to examine the brain-machine interface as part of the UAB Bevill Neuroscience Symposium on Feb. 27.  

   brain machineAmong the sharpest of cutting edges in science is the interface between machines and the brain, especially in the field of overcoming loss of motor function due to injury or disease. Leading scientists and engineers from around the nation and from the University of Alabama at Birmingham will gather for a symposium on the brain-machine interface at the 2015 Bevill Neuroscience Symposium. Sponsored by the UAB Comprehensive Neuroscience Center, the symposium will highlight the collaboration between the fields of engineering and medicine.

The event is all day Friday, Feb. 27, in the UAB Alumni House, at the corner of 10th Avenue South and 13th Street. Opening remarks begin at 8:30 a.m.

“Some of the nation’s leading figures in biomedical engineering will be in attendance,” said Lori McMahon, Ph.D., director of the UAB Comprehensive Neuroscience Center. “UAB will be well represented by speakers in areas such as psychology, psychiatry, neurology, radiation neurobiology, engineering, and physical medicine and rehabilitation.”

Featured speakers include:

  • Miguel Nicolelis, M.D., Ph.D., Duke University, who was the first to propose and demonstrate that animals and human subjects can use their electrical brain activity to directly control neuroprosthetic devices via brain-machine interfaces.
  • Andrew Schwartz, Ph.D., University of Pittsburgh, has developed a paradigm to explore cortical signals generated during volitional arm movements. His team has developed an algorithm to capture arm-movement data and has shown that a paralyzed patient who cannot move any part of her body below her neck can move a high-performance modular prosthetic limb intuitively in coordinated, graceful movements closely resembling natural arm and hand movements.  
  • Leigh Hochberg, M.D., Ph.D., Brown University and Massachusetts General Hospital, whose research focuses on the development and testing of novel neurotechnologies to help people with paralysis and other neurologic disorders, and on understanding cortical neuronal ensemble activities in neurologic disease.  
  • P. Hunter Peckham, Ph.D., Case Western Reserve University, focuses on functional restoration of the paralyzed upper extremity in individuals with spinal cord injury. He and collaborators developed three generations of implantable neural prostheses which use electrical stimulation to control neuromuscular activation.   
“The brain-machine interface represents a frontier at the intersection of medicine, science and engineering,” said Iwan Alexander, Ph.D., dean of UAB’s School of Engineering. “We are beginning to understand how to capture fundamental processes in the brain to stimulate electrical and mechanical responses in devices and machines. These advances point to a future rich in discovery that will yield exciting applications ranging from physical rehabilitation to thought-activated mechanical and electrical devices.”

“Since Hans Berger’s discovery of the ability to detect electrical activity of the human brain, and the ability to monitor this activity by electroencephalography (EEG), scientists have pursued the extension of this insight to the area of neuroprosthetics.  Early outcomes of this research include cochlear implants and others,” said Robert E. Palazzo, Ph.D., dean of the College of Arts and Sciences. “Recently, the extraordinary demonstration that implants in the brain’s motor cortex can transmit signals capable of directing the movement of robotic artificial limbs has ignited the promise of combining the science of the brain with the engineering of prosthetic devices. The promise for the development of integrated portable devices that overcome loss of hearing, loss of movement, and possibly even loss of sight is upon us.”

UAB speakers include Iwan Alexander, Ph.D., dean, School of Engineering; Robert Palazzo, Ph.D., dean, College of Arts and Sciences; Amie McLain, M.D., professor and chair, Department of Physical Medicine and Rehabilitation; David Standaert, M.D., Ph.D., professor and chair, Department of Neurology; Lori McMahon, Ph.D., director, Comprehensive Neuroscience Center; Adrienne Lahti, M.D., professor, Department of Psychiatry; Harrison Walker, M.D., associate professor, Department of Neurology; Rajesh Kana, Ph.D., associate professor, Department of Psychology; Mark Bolding, Ph.D., assistant professor, Department of Radiology; and Corey Shum, technical director, Enabling Technology Laboratory.

By: Bob Shephard - UAB Media